Evidence map›Paper›PMID 32905094›Full record

ArticleJournal of the Canadian Association of Gastroenterology2020

Directly Mailing gFOBT Kits to Previous Responders Being Recalled for Colorectal Cancer Screening Increases Participation.

Jill Tinmouth, Jigisha Patel, Peter C Austin, Nancy N Baxter, Melissa C Brouwers, Craig C Earle, Cheryl Levitt, Yan Lu, Marnie MacKinnon, Lawrence Paszat and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Canadian Association of Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Jill TinmouthSunnybrook Health Sciences Centre, Toronto, Ontario, Canada.ORCID 0000-0002-0264-2176
Jigisha PatelSunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Peter C AustinInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Nancy N BaxterInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Melissa C BrouwersDepartment of Oncology, McMaster University, Hamilton, Ontario, Canada.
Craig C EarleInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Cheryl LevittDepartment of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Yan LuCritical Care Services Ontario, University Health Network, Toronto, Ontario, Canada.
Marnie MacKinnonCancer Care Ontario, Toronto, Ontario, Canada.
Lawrence PaszatSunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Linda RabeneckInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Sunnybrook Health Science Centre · CAMcMaster University · CAUniversity of Toronto · CACancer Care Ontario · CAInstitute for Clinical Evaluative Sciences · CASt. Michael's Hospital · CAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) screening with guaiac fecal occult blood test (gFOBT) reduces CRC-related death. Average risk individuals should be recalled for screening with gFOBT every 2 years in order to maximize effectiveness. However, adherence with repeated testing is often suboptimal. Our aim was to evaluate whether adding a gFOBT kit to a mailed recall letter improves participation compared with a mailed recall letter alone, among previous responders to a mailed invitation.

methodsWe conducted a cluster randomized controlled trial, with the primary care provider as the unit of randomization. Eligible patients had completed a gFOBT and tested negative in an earlier pilot study and were now due for recall. The intervention group received a mailed CRC screening recall letter from their primary care provider plus a gFOBT kit (

resultsgFOBT uptake was higher in the intervention group (61.3%,

conclusionOur findings show that adding gFOBT kits to the mailed recall letter increased participation among persons recalled for screening. Nine gFOBT kits would have to be sent by mail in order to screen one additional person.

Indexed as

Colorectal cancerFecal occult blood testRandomized controlled trialScreening

Identifiers

PMID32905094
PMCPMC7464595
OpenAlexW2980948824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.